Finance

Beta
Lists
1795:TPE
Lotus Pharmaceutical Co Ltd
NT$191,50
+0,52%
(+1,00) 1D
30 Jun., 13:30:10 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1795...
Open
NT$193,00
High
NT$197,00
Low
NT$191,00
Mkt. cap
51,11 mjd
Avg. vol.
1,99 m
Volume
1,47 m
P/E ratio
12,99
52-wk high
NT$369,50
52-wk low
NT$182,00
EPS
NT$14,75
No. of employees
1 k
Open
NT$193,00
High
NT$197,00
Low
NT$191,00
Mkt. cap
51,11 mjd
Avg. vol.
1,99 m
Volume
1,47 m
P/E ratio
12,99
52-wk high
NT$369,50
52-wk low
NT$182,00
EPS
NT$14,75
No. of employees
1 k
News stories
From sources across the web
About Lotus Pharmaceutical Co Ltd
CEOPetar Vazharov
Employees1,1 k
Founded1966
Headquarters-
SectorPharmaceutical industry
Websitelotuspharm.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
4,75 mjd
4,77 mjd
6,26 mjd
8,64 mjd
Cost of goods sold
1,95 mjd
2,04 mjd
2,80 mjd
4,26 mjd
Cost of revenue
1,95 mjd
2,04 mjd
2,80 mjd
4,26 mjd
Research and development expenses
164,47 m
447,99 m
-33,26 m
279,59 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,13 mjd
1,10 mjd
1,70 mjd
2,14 mjd
Operating expense
1,29 mjd
1,54 mjd
1,67 mjd
2,43 mjd
Total operating expenses
3,24 mjd
3,58 mjd
4,47 mjd
6,69 mjd
Operating income
1,50 mjd
1,19 mjd
1,80 mjd
1,96 mjd
Other non operating income
100,31 m
-35,38 m
22,65 m
111,63 m
EBT including unusual items
827,29 m
1,83 mjd
1,32 mjd
725,90 m
EBT excluding unusual items
1,19 mjd
1,22 mjd
1,44 mjd
727,99 m
Income tax expense
99,03 m
397,56 m
194,58 m
158,70 m
Effective tax rate
11,97%
21,70%
14,78%
21,86%
Other operating expenses
-
-
-
-
Net income
728,26 m
1,43 mjd
1,12 mjd
567,20 m
Net profit margin
15,34%
30,07%
17,91%
6,56%
Earnings per share
2,79
5,53
4,32
2,00
Interest and investment income
31,89 m
27,63 m
31,75 m
33,26 m
Interest expense
-125,42 m
-123,20 m
-489,98 m
-1,21 mjd
Net interest expenses
-93,52 m
-95,58 m
-458,22 m
-1,17 mjd
Depreciation and amortization charges
-
-
-
-
EBITDA
1,84 mjd
1,53 mjd
2,21 mjd
2,54 mjd
Gain or loss from assets sale
10,35 m
-702,00 k
4,03 m
2,09 m
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer